PT  - JOURNAL ARTICLE
AU  - Redin, Esther
AU  - Garmendia, Irati
AU  - Lozano, Teresa
AU  - Serrano, Diego
AU  - Senent, Yaiza
AU  - Redrado, Miriam
AU  - Villalba, Maria
AU  - De Andrea, Carlos E
AU  - Exposito, Francisco
AU  - Ajona, Daniel
AU  - Ortiz-Espinosa, Sergio
AU  - Remirez, Ana
AU  - Bertolo, Cristina
AU  - Sainz, Cristina
AU  - Garcia-Pedrero, Juana
AU  - Pio, Ruben
AU  - Lasarte, Juan
AU  - Agorreta, Jackeline
AU  - Montuenga, Luis M
AU  - Calvo, Alfonso
TI  - SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation
AID  - 10.1136/jitc-2020-001496
DP  - 2021 Mar 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e001496
VI  - 9
IP  - 3
4099  - http://jitc.bmj.com/content/9/3/e001496.short
4100  - http://jitc.bmj.com/content/9/3/e001496.full
SO  - J Immunother Cancer2021 Mar 01; 9
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.